FDA rejects Amgen's application for Xgeva

(Reuters) - U.S. health regulators rejected the application by Amgen Inc, the world's biggest biotechnology company, to expand the use of the drug Xgeva to delay the spread of tumors to the bone in patients suffering from advanced prostate cancer.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/74UIqvQk4GY/us-amgen-idUSBRE83Q05M20120427

online money internet business Current news latest news top news recent news